Skip to content

THALEN BIOTECH CONSULTANCY

Active Private limited companyfounded 2015active for 11 yearsBois de Martimont 7, 7911 Frasnes-lez-AnvaingKBO/BCE: BE 0607.985.607

Lifetime

11 annual accounts with figures on one time axis
peak of €221,552 in 2025
€221,552▲ 6.8%
peak of €166,089 in 2025
€166,089▲ 6.8%
peak of €132,666 in 2017
€18,550unchanged
€197,000▲ 10.5%
Board1 name since 2015
1 director
Documentsfilings and deeds
24-06-202637 days before the deadline
2025micro format
Dividend €166,089

Key points

from the 2025 annual accounts

Equity

€18,550 from €132,666 in 2017

Equity fell by 86% in 8 years.

Debts

€197,000 91% of the balance sheet
Suppliers 1%Taxes and wages 17%Other 82%

Of this, €193,581 falls due within a year.

Filings

11 annual accounts since 2015
AprilJune31 JulyOctober201520202025

The 2016 accounts came 9 days late. The other nine of the last ten were filed on time.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 1,326 companies had the same profile as THALEN BIOTECH CONSULTANCY has now. Each dot stands for 4 companies, two years later.

95.1%
were still trading
3.2%
stopped another way
1.5%
went bankrupt
  • Micro
  • 10 to 20 years old
  • solvency under 10%
  • a profit of 5% of the balance sheet or more

Another 0.2% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,894 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 1,326 companies, not a prediction for THALEN BIOTECH CONSULTANCY. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • 1,200 sharesdeed of 07-04-2015
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0607985607
appointed as director General meeting of 07-09-2023 · Gazette deed
Registered office moved from Rumes to Frasnes-Lez-Arivaing The registered office moved from Rue Royale, 7611 Rumes to Bois de Martimort 7 à 7911 Frasnes-Lez-Arivaing · General meeting of 01-07-2017 · Gazette deed
Incorporation Founding capital of €18,550, 1,200 shares, €12,400 paid up · Founded by · appointed as manager · published on 07-04-2015 · Gazette deed
All 18 events

Comparable companies

same main activity, similar in size and age
Company
THALEN BIOTECH CONSULTANCY Frasnes-lez-Anvaing €215,550 €221,552 8.6% -
STXC Aalst €210,455 €242,147 94.9% -
BIOSILARIS Huy €261,445 €93,489 85.0% -
CRz Services Spa €251,152 €82,779 11.6% -
SUSTAINEER Ghent €299,595 €116,857 74.3% -
Oteas Heist-op-den-Berg €193,883 €63,597 27.3% -
ELANDD Bonheiden €129,408 €85,268 38.0% -

These companies have the same main activity as THALEN BIOTECH CONSULTANCY: research and development on biotechnology (NACE 72101). They are comparable in size and age: total assets between €129,000 and €300,000, founded between 2014 and 2016.

Official details

Source: KBO
Status
Active since 25-03-2015Normal situation
Activity
Research and development on biotechnologyNACE 72101and 3 others
Establishment unit
2.240.868.7597611 Rumes, since 25-03-2015
Financial year end
31 December
Peppol
Reachable since 19-11-2025
Company details

Annual accounts 2025

≈ €550,000estimated
€215,550▲ 9.5%
Filing
Filed on 24-06-2026, 37 days before the end of the filing period
Financials

Insights on THALEN BIOTECH CONSULTANCY

THALEN BIOTECH CONSULTANCY files the micro format. That format states no turnover. The gross margin rose from €102,517 in 2015 to €221,552 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about THALEN BIOTECH CONSULTANCY

What is the company number of THALEN BIOTECH CONSULTANCY?
The company number of THALEN BIOTECH CONSULTANCY is 0607.985.607. The VAT number is the same number with BE in front: BE 0607.985.607.
Where is THALEN BIOTECH CONSULTANCY based?
The registered office is at Bois de Martimont 7, 7911 Frasnes-lez-Anvaing.Company details
What does THALEN BIOTECH CONSULTANCY do?
According to the KBO register, the main activity is research and development on biotechnology (NACE 72101).
What is the legal form of THALEN BIOTECH CONSULTANCY?
THALEN BIOTECH CONSULTANCY is a private limited company (BV).
When was THALEN BIOTECH CONSULTANCY founded?
THALEN BIOTECH CONSULTANCY was founded on 25-03-2015.
Is THALEN BIOTECH CONSULTANCY still active?
Yes, THALEN BIOTECH CONSULTANCY is an active enterprise in the KBO register.
What is the turnover of THALEN BIOTECH CONSULTANCY?
The turnover in financial year 2025 is about €550,000. This figure is estimated from the gross margin of €221,552 and 2,452 comparable companies of the same size. It probably lies between €370,000 and €850,000. It is a rough estimate.Financials
Is THALEN BIOTECH CONSULTANCY profitable?
In financial year 2025, THALEN BIOTECH CONSULTANCY made a profit of €166,089.
Where can I find the annual accounts of THALEN BIOTECH CONSULTANCY?
THALEN BIOTECH CONSULTANCY filed 11 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of THALEN BIOTECH CONSULTANCY due?
THALEN BIOTECH CONSULTANCY must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.